+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 65Years +
All Genders
ID07432737

Comparing One Dose Versus Two Doses of Tranexamic Acid to Reduce Blood Loss in Older Adults Undergoing Surgery for Certain Hip Fractures

Led by University Hospital for Surgical Diseases St. Naum Ohridsk i- Skopje · Updated on 2026-02-27

120

Participants Needed

1

Research Sites

17 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating whether giving one dose or two doses of tranexamic acid can safely reduce blood loss in adults aged 65 years or older undergoing surgery for certain hip fractures, specifically pertrochanteric or subtrochanteric femoral fractures. The study aims to determine if two doses lower the need for blood transfusions compared to one dose, whether tranexamic acid helps maintain higher hemoglobin levels after surgery, and if it is safe for this patient group. Participants are randomly assigned to receive either a single intravenous dose of 15 mgkg tranexamic acid before surgery followed by a placebo, or two doses of 15 mgkg tranexamic acid, one before surgery and a second three hours later. All participants undergo standard surgical treatment within 48 hours of hospital admission, with surgery performed under spinal or general anesthesia using fixation devices appropriate for fracture type. Postoperative care includes antibiotic and thromboprophylaxis protocols, and monitoring for complications and adverse events. During the hospital stay, researchers measure blood loss using visible and calculated methods, monitor hemoglobin and other laboratory values daily for up to three days, and record transfusions and complications. Participants are followed for safety and recovery with outpatient visits at 14 days, 1 month, 2 months, and 3 months post-surgery. The main outcome measured is the incidence of blood transfusions through postoperative day 5, with additional outcomes including hemoglobin drop, blood loss, thrombotic events, mortality, and length of hospital stay.

CONDITIONS

Brief Title

One Versus Two Doses of Tranexamic Acid in Surgically Treated Extracapsular Hip Fractures

Research Team

A

Angelina Krsteva, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here